Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials

Bioorg Med Chem Lett. 2007 Apr 15;17(8):2361-4. doi: 10.1016/j.bmcl.2006.12.049. Epub 2006 Dec 21.

Abstract

Antimicrobial peptides have been recognized as a novel class of antibiotics, and several candidates are currently in clinical trials. In this work, a tripeptide derivative containing 4-iodo phenylalanine has been derivatized through the Suzuki-Miyaura cross-coupling. This has enabled the rapid and efficient synthesis of an array of tripeptide derivatives encompassing novel biaryl moieties. The peptide derivatives show high activity against Gram-positive bacteria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology*
  • Calcium Signaling
  • DNA-Binding Proteins / antagonists & inhibitors
  • Humans
  • Inhibitory Concentration 50
  • Mice
  • Patch-Clamp Techniques
  • Pharmacokinetics
  • Protein Binding
  • Receptors, Somatostatin / antagonists & inhibitors
  • Trans-Activators / antagonists & inhibitors
  • Transcriptional Regulator ERG

Substances

  • Anti-Bacterial Agents
  • DNA-Binding Proteins
  • ERG protein, human
  • MCHR1 protein, human
  • Receptors, Somatostatin
  • Trans-Activators
  • Transcriptional Regulator ERG